• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude closes $200M NeuroTherm buy

St. Jude closes $200M NeuroTherm buy

August 7, 2014 By Arezu Sarvestani

St. Jude closes $200M NeuroTherm buy

Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.

The deal makes St. Jude the only company in the space with both radiofrequency ablation devices, which came from NeuroTherm, in addition to spinal cord stimulation systems in its chronic pain product portfolio. St. Jude has been bulking up its pain management technologies substantially in recent months.

"Over the last year, we have launched 2 novel neuromodulation products, made a strategic investment in Spinal Modulation, and initiated 2 multi-center, randomized clinical studies to evaluate alternatives for patients living with chronic pain," St. Jude COO Michael Rousseau said in prepared remarks. "This acquisition further demonstrates St. Jude Medical’s commitment to our chronic pain program and our steadfast focus on improving patient outcomes."

St. Jude expects NeuroTherm to add about $10-$15 million to 2014 revenues. Excluding acquisition-related costs, the deal is expected to be neutral to St. Jude’s per-share earnings for the year, but will be accretive thereafter.

NeuroTherm develops minimally invasive radiofrequency ablation systems, intradiscal catheters and a suite of vertebral augmentation technologies. The company was built in part on a 2010 acquisition of Smith & Nephew’s (FTSE:SN, NYSE:SNN) spine pain management line, the terms of which were not disclosed.

ST. Jude’s stock didn’t benefit much from today’s news. STJ shares dropped 1.8% to $63.75 as of about 2:10 p.m. EST.

Filed Under: Mergers & Acquisitions, News Well, Pain Management, Spine Tagged With: Ablation, Minnesota, NeuroTherm Inc., stjudemedical

More recent news

  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out
  • Former Masimo COO is joining BD to run Connected Care

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy